Beyond preventing the painful reactivation of the chickenpox virus, the dementia-new-study-reveals-surprising-connection/” title=”… Link to …: New Study Reveals Surprising Connection”>Shingrix vaccine may offer a surprising benefit: protection against dementia. New research from Cardiff University links the widely-used vaccine to a potential 30% reduction in dementia-related mortality, adding to a growing body of evidence suggesting a connection between vaccination and long-term brain health [[1]], [[2]], [[3]].Published in the journal *Cell*, the study highlights the vaccine’s potential to slow cognitive decline and reduce chronic inflammation, a key factor in neurodegenerative diseases.
A widely used shingles vaccine may significantly reduce the risk of death associated with dementia, according to a new study from Cardiff University in the United Kingdom. Researchers found the vaccine linked to up to a 30% decrease in dementia-related mortality after analyzing extensive vaccination program data.
The research, published in the scientific journal Cell, indicates that individuals who received the vaccine experienced slower cognitive decline and were less likely to develop dementia symptoms. This protective effect extends beyond preventing shingles, offering additional benefits for brain and nervous system health.
Study participants who were vaccinated showed a noticeable reduction in death rates from dementia across all age groups and stages of the disease. Researchers attribute this to the vaccine’s ability to reduce chronic inflammation, a known factor in accelerating the deterioration of nerve cells. Understanding the link between inflammation and neurodegenerative diseases is a growing area of public health research.
The Shingrix vaccine is currently the most recommended and effective option for preventing shingles, a painful viral disease caused by the reactivation of the varicella-zoster virus – the same virus that causes chickenpox – in the nerves. Shingrix has demonstrated over 90% effectiveness in preventing shingles in older adults.
